
The Slow and Winding Path to Pharmacogenomic Test Adoption
A cornerstone of precision medicine, pharmacogenomic testing allows drug treatment for a disease to be tailored to a person’s genetic makeup. Despite a large amount of research having been carried out in this area from the 1990s onward, only a few of the findings have reached the clinic in the form of tests.
High costs, unreliable data, and a lack of physician education have been cited as reasons for this slow adoption, but recent developments like improvements in data and guidelines, reductions...
High costs, unreliable data, and a lack of physician education have been cited as reasons for this slow adoption, but recent developments like improvements in data and guidelines, reductions...